You are here

ABZYME THERAPEUTICS LLC

Company Information
Address
321 JONES BLVD STE 300
POTTSTOWN, PA 19464-3468
United States


http://www.abzymetx.com

Information

UEI: H2MLEFWV36N6

# of Employees: 8


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Novel approach for rapid generation of human antibodies to RNA-modifications

    Amount: $224,638.00

    Project Summary It is known that protein activity can be modulated by post translational protein phosphorylation Phospho specific antibodies have greatly advanced understanding of the mechanisms of ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  2. High throughput camelid antibody screening as a drug discovery platform

    Amount: $1,670,345.00

    ABSTRACTMonoclonal antibodies are used for treatment of a wide range of diseases from cancer to infectious diseasesHoweverdevelopment of antibodies with high affinity and specificity is still timecons ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  3. Single domain antibodies as medical countermeasures for viral induced encephalitis

    Amount: $149,656.60

    Alphavirus infection, which may cause encephalitis and death, are recognized as potential biological warfare agents. There are no approved medical countermeasures against diseases caused by Alphavirus ...

    SBIRPhase I2016Department of Defense Office for Chemical and Biological Defense
  4. An Instant Estrogen Sensor for Poultry Gender Sorting Automation

    Amount: $99,943.00

    The need for segregation of poultry based on sex is driven by gender-related differences in growth rate, market age, management practices, and nutritional requirements. Each day, global poultry indust ...

    SBIRPhase I2015Department of Agriculture
  5. Hybridoma-free multiplex approach for accelerating mouse monoclonal antibody generation

    Amount: $264,747.00

    DESCRIPTION provided by applicant Thanks to their exquisite specificity and sensitivity monoclonal antibodies Mab are the most important research tool for detection localization and quantificat ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  6. Nanobodies for topical delivery to inhibit abnormal choroidal angiogenesis

    Amount: $224,935.00

    DESCRIPTION provided by applicant The age related macular degeneration AMD characterized by the formation of subretinal choroidal neovascularization is the main cause of blindness in the elderly ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  7. High throughput approach for generating human monoclonal antibodies

    Amount: $224,799.00

    DESCRIPTION provided by applicant Thanks to their exquisite specificity and sensitivity monoclonal antibodies Mab have found a broad application in research diagnosis and therapy For treatment ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  8. Novel bispecific T cell engaging antibodies for treatment of Lyme disease

    Amount: $224,849.00

    DESCRIPTION (provided by applicant): Lyme disease (LD) is the most commonly reported tick-borne illness in the United States. According to the recent Center for Disease Control and Prevention report, ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  9. Nanobodies for detecting and manipulating A to I editing enzymes and their modified RNA products

    Amount: $224,975.00

    DESCRIPTION (provided by applicant): Adenosine to inosine or A-to-I RNA editing executed by ADAR family proteins is abundant in the central nervous system (CNS). The availability of tools to monitor a ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  10. High throughput camelid antibody screening as drug discovery platform

    Amount: $218,085.00

    DESCRIPTION (provided by applicant): Monoclonal antibodies are used for treatment of a wide range of diseases from cancer to infectious diseases. However, development of antibodies with high affinity ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government